Skip to main content
OpenTrials

Clinical trial condition

Muscular Diseases

Explore clinical trials studying Muscular Diseases. Study availability and eligibility vary by location and protocol.

4,853 public trials 733 recruiting studies
Refine in advanced search Browse all conditions

Muscular Diseases trial results

Completed

Study of Eteplirsen in DMD Patients

NCT02255552

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Rady Children's Hospital, U.C. San Diego San Diego, California, United States
View all 37 locations
View Trial Details
Completed

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

NCT02420379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • Neuromuscular Research Center of Arizona Phoenix, Arizona, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 13 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia

NCT00645398

Conditions
Fibromyalgia, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Paradise Valley, Arizona, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
View all 102 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

NCT03263715

Conditions
Connective Tissue Diseases, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Medizinische Universität Graz, Klinische Abteilung für Rheumatologie und Immunologie Graz, Austria
  • Allgemeines Krankenhaus der Stadt Wien Vienna, Austria
  • Krankenhaus Hietzing, 2. Medizinische Abteilung Vienna, Austria
View Trial Details
Completed

This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia

NCT00346034

Conditions
Fibromyalgia, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Pfizer Investigational Site Kelowna, British Columbia, Canada
  • Pfizer Investigational Site Winnipeg, Manitoba, Canada
  • Pfizer Investigational Site Bathurst, New Brunswick, Canada
  • Pfizer Investigational Site St. John's, Newfoundland and Labrador, Canada
View all 51 locations
View Trial Details
Completed

A Safety Study Of Pregabalin In Fibromyalgia

NCT00282997

Conditions
Fibromyalgia, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Fresno, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Northridge, California, United States
View all 72 locations
View Trial Details
Completed

Safety and Efficacy Study of Pregabalin in Fibromyalgia

NCT00151489

Conditions
Fibromyalgia, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Pfizer Investigational Site Anniston, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Calera, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
View all 109 locations
View Trial Details

Related conditions